The Symptomatic Cerebral Cavernous Malformation Trial of REC-994
Trial details
- Registry ID
- NCT05085561
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| The Symptomatic Cerebral Cavernous Malformation Trial of REC-994NCT05085561 | RXRX | Phase 2 | Completed | 2025-06-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |